Skip to content

Cross-sectional study of host immune responses stimulated by bifidobacteria and lactobacilli in relation to intestinal microbiota and lifestyle

Cross-sectional study of host immune responses stimulated by bifidobacteria and lactobacilli in relation to intestinal microbiota and lifestyle - Cross-sectional study of host immune responses stimulated by bifidobacteria and lactobacilli in relation to intestinal microbiota and lifestyle

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000052004
Enrollment
60
Registered
2023-08-25
Start date
2023-08-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

None listed

Sponsors

MORINAGA MILK INDUSTRY CO.,LTD.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Subjects of both sexes aged 18 years or older.

Exclusion criteria

Exclusion criteria: 1)Subjects with serious disorders on malignant tumors, respiratory disease, hepatic, kidney, cardiac, lung, digestive organs, blood, endocrine system and metabolic system, or related severe past medical histories 2)Subjects with medication allergy, food allergy, or serious history of these 3)Subjects who are pregnant, under lactation or expecting to be pregnant during this study 4)Subjects with suffering from autoimmune diseases 5)Subjects who plan to use drugs that may affect immune response and intestinal flora (antiallergic agents, anti-inflammatory agents, antibiotics, drugs for digestive system treatment, diabetes drugs) from the time consent is obtained to the end of the study. 6)Subjects who plan to be vaccinated against influenza, COVID-19, or other infectious diseases from the time consent is obtained to the end of the study. 7)Any candidates considered to be inappropriate for this study by the principal investigator based on their background, physical examination, etc.

Design outcomes

Primary

MeasureTime frame
Evaluation of immunity parameters, Intestinal flora, Survey of background information on the subject

Countries

Japan

Contacts

Public ContactTatsuki Nishimura

MORINAGA MILK INDUSTRY CO.,LTD. Innovative Research Institute R&D Division

tatsuki-nishimura871@morinagamilk.co.jp046-252-3067

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026